Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Dose Comparison in PENG Block for Total Hip Replacement
NCT04900116Completed
- Sponsor
- Istanbul University
- Start
- Jun 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (4 arms), sponsored by Istanbul University. Primary endpoint: Visual Analogue Scale Pain Score at 48 hours. Started Jun 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04900116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04900116.